Skip Header

Contribute Send feedback
Read comments (?) or add your own

P06493 (CDK1_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified May 16, 2012. Version 166. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
to top of pageNames·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Cyclin-dependent kinase 1
Short name=CDK1
EC=2.7.11.22
EC=2.7.11.23
Alternative name(s):
Cell division control protein 2 homolog
Cell division protein kinase 1
p34 protein kinase
Gene names
Name:CDK1
Synonyms:CDC2, CDC28A, CDKN1, P34CDC2
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo

Protein attributes

Sequence length297 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins. Required in higher cells for entry into S-phase and mitosis. Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, UL40/R2, RAB4A, RAP1GAP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1 and RUNX2. CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs. Essential for early stages of embryonic development. During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation. Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis. Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair. Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression. In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons. The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis. The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis. In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis. This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration. Ref.18 Ref.19 Ref.23 Ref.28 Ref.32 Ref.34 Ref.39 Ref.40 Ref.42 Ref.43 Ref.44 Ref.45 Ref.47

Catalytic activity

ATP + a protein = ADP + a phosphoprotein.

ATP + [DNA-directed RNA polymerase] = ADP + [DNA-directed RNA polymerase] phosphate.

Enzyme regulation

Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-161 activates it. Activated through a multistep process; binding to cyclin-B is required for relocation of cyclin-kinase complexes to the nucleus, activated by CAK/CDK7-mediated phosphorylation on Thr-161, and CDC25-mediated dephosphorylation of inhibitory phosphorylation on Thr-14 and Tyr-15. Inhibited by flavopiridol and derivatives, pyrimidine derivatives, pyridine derivatives, purine derivatives, staurosporine, paullones, oxoindoles, indazole analogs, indolin-2-ones, pyrazolo[3,4-b]pyridines, imidazo[1,2-a]pyridine (AZ703), thiazolinone analogs(RO-3306), thiazol urea, macrocyclic quinoxalin-2-one, pyrrolo[2,3-a]carbazole, pyrazolo[1,5-a]-1,3,5-triazine, pyrazolo[1,5-a]pyrimidine (Dinaciclib, SCH 727965), 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine), olomoucine, AG-024322, AT-7519, P276-00, R547/Ro-4584820 and SNS-032/BMS-387032. Repressed by the CDK inhibitors CDKN1A/p21 and CDKN1B/p27 during the G1 phase and by CDKN1A/p21 at the G1-S checkpoint upon DNA damage. Transient activation by rapid and transient dephosphorylation at Tyr-15 triggered by TGFB1. Ref.12 Ref.23

Subunit structure

Forms a stable but non-covalent complex with a regulatory subunit and with a cyclin. Interacts with cyclins-B (CCNB1, CCNB2 and CCNB3) to form a serine/threonine kinase holoenzyme complex also known as maturation promoting factor (MPF). The cyclin subunit imparts substrate specificity to the complex. Can also form CDK1-cylin-D and CDK1-cyclin-E complexes that phosphorylate RB1 in vitro. Binds to RB1 and other transcription factors such as FOXO1 and RUNX2. Promotes G2-M transition when in complex with a cyclin-B. Interacts with DLGAP5. Binds to the CDK inhibitors CDKN1A/p21 and CDKN1B/p27. Isoform 2 is unable to complex with cyclin-B1 and also fails to bind to CDKN1A/p21. Interacts with catalytically active CCNB1 and RALBP1 during mitosis to form an endocytotic complex during interphase. Associates with cyclins-A and B1 during S-phase in regenerating hepatocytes. Interacts with FANCC. Ref.11 Ref.13 Ref.14 Ref.32 Ref.42

Subcellular location

Nucleus. Cytoplasm. Mitochondrion. Note: Cytoplasmic during the interphase. Reversibly translocated from cytoplasm to nucleus when phosphorylated before G2-M transition when associated with cyclin-B1. Accumulates in mitochondria in G2-arrested cells upon DNA-damage. Ref.43

Tissue specificity

Isoform 2 is found in breast cancer tissues.

Induction

Follows a cyclic expression; during interphase, accumulates gradually following G1, S to reach a critical threshold at the end of G2, which promotes self-activation and triggers onset of mitosis. Induced transiently by TGFB1 at an early phase of TGFB1-mediated apoptosis, but later repressed. Triggered by CKS1B during mitotic entry in breast cancer cells. Down-regulated under genotoxic stresses triggered by PKR/EIF2AK2-mediated phosphorylation. Ref.12 Ref.21 Ref.23

Post-translational modification

Phosphorylation at Thr-161 by CAK/CDK7 activates kinase activity. Phosphorylation at Thr-14 and Tyr-15 by PKMYT1 prevents nuclear translocation. Phosphorylation at Tyr-15 by WEE1 and WEE2 inhibits the protein kinase activity and acts as a negative regulator of entry into mitosis (G2 to M transition). Phosphorylation by PKMYT1 and WEE1 takes place during mitosis to keep CDK1-cyclin-B complexes inactive until the end of G2. By the end of G2, PKMYT1 and WEE1 are inactivated, but CDC25A and CDC25B are activated. Dephosphorylation by active CDC25A and CDC25B at Thr-14 and Tyr-15, leads to CDK1 activation at the G2-M transition. Phosphorylation at Tyr-15 by WEE2 during oogenesis is required to maintain meiotic arrest in oocytes during the germinal vesicle (GV) stage, a long period of quiescence at dictyate prophase I, leading to prevent meiotic reentry. Phosphorylation by WEE2 is also required for metaphase II exit during egg activation to ensure exit from meiosis in oocytes and promote pronuclear formation. Phosphorylated at Tyr-4 by PKR/EIF2AK2 upon genotoxic stress. This phosphorylation triggers CDK1 polyubiquitination and subsequent proteolysis, thus leading to G2 arrest. In response to UV irradiation, phosphorylation at Tyr-15 by PRKCD activates the G2/M DNA damage checkpoint. Ref.9 Ref.10 Ref.15 Ref.16 Ref.17 Ref.20 Ref.22 Ref.24 Ref.25 Ref.26 Ref.27 Ref.29 Ref.30 Ref.33 Ref.35 Ref.36 Ref.37 Ref.40 Ref.41 Ref.42

Polyubiquitinated upon genotoxic stress.

Miscellaneous

As a key regulator of the cell cycle, CDK1 is a potent therapeutic target for inhibitors in cancer treatment (Ref.52).

Sequence similarities

Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.

Contains 1 protein kinase domain.

Sequence caution

The sequence EAW54204.1 differs from that shown. Reason: Erroneous gene model prediction.

Ontologies

Keywords
   Biological processApoptosis
Cell cycle
Cell division
Mitosis
   Cellular componentCytoplasm
Mitochondrion
Nucleus
   Coding sequence diversityAlternative splicing
   LigandATP-binding
Nucleotide-binding
   Molecular functionKinase
Serine/threonine-protein kinase
Transferase
   PTMAcetylation
Isopeptide bond
Phosphoprotein
Ubl conjugation
   Technical term3D-structure
Complete proteome
Reference proteome
Gene Ontology (GO)
   Biological processDNA repair

Traceable author statement Ref.53. Source: UniProtKB

DNA replication

Traceable author statement Ref.53. Source: UniProtKB

MyD88-dependent toll-like receptor signaling pathway

Traceable author statement. Source: Reactome

Ras protein signal transduction

Traceable author statement. Source: Reactome

TRIF-dependent toll-like receptor signaling pathway

Traceable author statement. Source: Reactome

Toll signaling pathway

Traceable author statement. Source: Reactome

activation of MAPK activity

Traceable author statement. Source: Reactome

activation of MAPKK activity

Traceable author statement. Source: Reactome

anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process

Traceable author statement. Source: Reactome

anti-apoptosis

Inferred from direct assay PubMed 11069302. Source: UniProtKB

apoptotic process

Inferred from electronic annotation. Source: UniProtKB-KW

axon guidance

Traceable author statement. Source: Reactome

cell division

Inferred from electronic annotation. Source: UniProtKB-KW

cell migration

Traceable author statement PubMed 17200138. Source: UniProtKB

centrosome cycle

Traceable author statement Ref.49. Source: UniProtKB

epidermal growth factor receptor signaling pathway

Traceable author statement. Source: Reactome

fibroblast growth factor receptor signaling pathway

Traceable author statement. Source: Reactome

innate immune response

Traceable author statement. Source: Reactome

insulin receptor signaling pathway

Traceable author statement. Source: Reactome

mitosis

Inferred from electronic annotation. Source: UniProtKB-KW

nerve growth factor receptor signaling pathway

Traceable author statement. Source: Reactome

positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle

Traceable author statement. Source: Reactome

pronuclear fusion

Traceable author statement Ref.51. Source: UniProtKB

protein localization to kinetochore

Inferred from direct assay PubMed 18195732. Source: BHF-UCL

regulation of Schwann cell differentiation

Traceable author statement PubMed 17200138. Source: UniProtKB

regulation of embryonic development

Traceable author statement Ref.51. Source: UniProtKB

regulation of transcription involved in G1/S phase of mitotic cell cycle

Traceable author statement. Source: Reactome

stress-activated MAPK cascade

Traceable author statement. Source: Reactome

toll-like receptor 1 signaling pathway

Traceable author statement. Source: Reactome

toll-like receptor 2 signaling pathway

Traceable author statement. Source: Reactome

toll-like receptor 3 signaling pathway

Traceable author statement. Source: Reactome

toll-like receptor 4 signaling pathway

Traceable author statement. Source: Reactome

   Cellular componentcytosol

Traceable author statement. Source: Reactome

midbody

Inferred from direct assay PubMed 11069302. Source: UniProtKB

mitochondrion

Traceable author statement Ref.43. Source: UniProtKB

nucleoplasm

Traceable author statement. Source: Reactome

spindle microtubule

Inferred from direct assay PubMed 11069302. Source: UniProtKB

   Molecular functionATP binding

Inferred from electronic annotation. Source: UniProtKB-KW

RNA polymerase II carboxy-terminal domain kinase activity

Inferred from direct assay PubMed 12721286. Source: UniProtKB

cyclin-dependent protein kinase activity

Inferred from direct assay PubMed 11069302PubMed 18477460. Source: UniProtKB

Complete GO annotation...

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: P06493-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: P06493-2)

Also known as: CDC2deltaT;

The sequence of this isoform differs from the canonical sequence as follows:
     107-163: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 297297Cyclin-dependent kinase 1
PRO_0000085724

Regions

Domain4 – 287284Protein kinase
Nucleotide binding10 – 189ATP By similarity

Sites

Active site1281Proton acceptor By similarity
Binding site331ATP By similarity

Amino acid modifications

Modified residue11N-acetylmethionine Ref.38
Modified residue41Phosphotyrosine; by PKR Ref.36 Ref.40
Modified residue51Phosphothreonine Ref.29 Ref.36
Modified residue61N6-acetyllysine Ref.38
Modified residue141Phosphothreonine; by PKMYT1 Ref.10 Ref.15 Ref.24 Ref.26 Ref.29 Ref.30 Ref.33 Ref.36 Ref.37 Ref.42
Modified residue151Phosphotyrosine; by PKMYT1, WEE1, WEE2 and PKC/PRKCD Ref.10 Ref.15 Ref.16 Ref.17 Ref.22 Ref.24 Ref.26 Ref.29 Ref.30 Ref.33 Ref.35 Ref.36 Ref.37 Ref.41 Ref.42
Modified residue191Phosphotyrosine Ref.17 Ref.22 Ref.26 Ref.29 Ref.33 Ref.35 Ref.36 Ref.37
Modified residue391Phosphoserine Ref.29 Ref.36
Modified residue461Phosphoserine Ref.36
Modified residue771Phosphotyrosine Ref.29
Modified residue1411Phosphothreonine Ref.36
Modified residue1601Phosphotyrosine Ref.27 Ref.36
Modified residue1611Phosphothreonine; by CAK Ref.20 Ref.25 Ref.27 Ref.29 Ref.36 Ref.37 Ref.42
Modified residue1781Phosphoserine Ref.36
Modified residue1811Phosphotyrosine Ref.36
Modified residue2221Phosphothreonine Ref.29 Ref.36
Modified residue2331Phosphoserine Ref.36
Modified residue2481Phosphoserine Ref.36
Cross-link89Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.31

Natural variations

Alternative sequence107 – 16357Missing in isoform 2.
VSP_021375

Experimental info

Mutagenesis41Y → D or E: Constitutive polyubiquitination. Ref.28 Ref.40
Mutagenesis14 – 152TY → AF: Abnormal cell cycle exhibiting only M-phase without completing either karyokinesis or cytokinesis. Ref.28

Secondary structure

1 ................................................. 297
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified May 31, 2011. Version 3.
Checksum: 942D79448EFE490A

FASTA29734,095
        10         20         30         40         50         60 
MEDYTKIEKI GEGTYGVVYK GRHKTTGQVV AMKKIRLESE EEGVPSTAIR EISLLKELRH 

        70         80         90        100        110        120 
PNIVSLQDVL MQDSRLYLIF EFLSMDLKKY LDSIPPGQYM DSSLVKSYLY QILQGIVFCH 

       130        140        150        160        170        180 
SRRVLHRDLK PQNLLIDDKG TIKLADFGLA RAFGIPIRVY THEVVTLWYR SPEVLLGSAR 

       190        200        210        220        230        240 
YSTPVDIWSI GTIFAELATK KPLFHGDSEI DQLFRIFRAL GTPNNEVWPE VESLQDYKNT 

       250        260        270        280        290 
FPKWKPGSLA SHVKNLDENG LDLLSKMLIY DPAKRISGKM ALNHPYFNDL DNQIKKM

« Hide

Isoform 2 (CDC2deltaT) [UniParc].

Checksum: 50FC3D192024E38C
Show »

FASTA24027,503

References

« Hide 'large scale' references
[1]"Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2."
Lee M.G., Nurse P.
Nature 327:31-35(1987) [PubMed: 3553962] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
[2]"T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21."
Ohta T., Okamoto K., Isohashi F., Shibata K., Fukuda M., Yamaguchi S., Xiong Y.
Cancer Res. 58:1095-1098(1998) [PubMed: 9515786] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
Tissue: Mammary cancer.
[3]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
[4]"Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
[5]NIEHS SNPs program
Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[6]"The DNA sequence and comparative analysis of human chromosome 10."
Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. expand/collapse author list , Bird C.P., Ainscough R., Almeida J.P., Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.
Nature 429:375-381(2004) [PubMed: 15164054] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[7]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[8]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Tissue: Skin.
[9]"Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement."
Draetta G., Beach D.
Cell 54:17-26(1988) [PubMed: 3289755] [Abstract]
Cited for: PHOSPHORYLATION, ASSOCIATION WITH P13.
[10]"Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15."
Mueller P.R., Coleman T.R., Kumagai A., Dunphy W.G.
Science 270:86-90(1995) [PubMed: 7569953] [Abstract]
Cited for: PHOSPHORYLATION AT THR-14 AND TYR-15 BY PKMYT1.
[11]"The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2."
Kupfer G.M., Yamashita T., Naf D., Suliman A., Asano S., D'Andrea A.D.
Blood 90:1047-1054(1997) [PubMed: 9242535] [Abstract]
Cited for: INTERACTION WITH FANCC.
[12]"Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5."
Meijer L., Borgne A., Mulner O., Chong J.P.J., Blow J.J., Inagaki N., Inagaki M., Delcros J.-G., Moulinoux J.-P.
Eur. J. Biochem. 243:527-536(1997) [PubMed: 9030781] [Abstract]
Cited for: ENZYME REGULATION BY ROSCOVITINE AND OLOMOUCINE.
[13]"RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis."
Rosse C., L'Hoste S., Offner N., Picard A., Camonis J.
J. Biol. Chem. 278:30597-30604(2003) [PubMed: 12775724] [Abstract]
Cited for: INTERACTION WITH RALBP1.
[14]"Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region."
Hsu J.-M., Lee Y.-C.G., Yu C.-T.R., Huang C.-Y.F.
J. Biol. Chem. 279:32592-32602(2004) [PubMed: 15145941] [Abstract]
Cited for: INTERACTION WITH DLGAP5.
[15]"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."
Kim J.-E., Tannenbaum S.R., White F.M.
J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND TYR-15, MASS SPECTROMETRY.
Tissue: Colon adenocarcinoma.
[16]"Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules."
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J., Lauffenburger D.A., White F.M.
Mol. Cell. Proteomics 4:1240-1250(2005) [PubMed: 15951569] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, MASS SPECTROMETRY.
Tissue: Mammary epithelium.
[17]"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J.
Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15 AND TYR-19, MASS SPECTROMETRY.
[18]"Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation."
Qiao M., Shapiro P., Fosbrink M., Rus H., Kumar R., Passaniti A.
J. Biol. Chem. 281:7118-7128(2006) [PubMed: 16407259] [Abstract]
Cited for: FUNCTION AS RUNX2 KINASE.
[19]"Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-dependent kinase Cdk1."
Fourest-Lieuvin A., Peris L., Gache V., Garcia-Saez I., Juillan-Binard C., Lantez V., Job D.
Mol. Biol. Cell 17:1041-1050(2006) [PubMed: 16371510] [Abstract]
Cited for: FUNCTION AS BETA-TUBULINS KINASE.
[20]"Phosphoproteome analysis of the human mitotic spindle."
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161, MASS SPECTROMETRY.
Tissue: Cervix adenocarcinoma.
[21]"Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells."
Westbrook L., Manuvakhova M., Kern F.G., Estes N.R. II, Ramanathan H.N., Thottassery J.V.
Cancer Res. 67:11393-11401(2007) [PubMed: 18056467] [Abstract]
Cited for: INDUCTION BY CKS1B.
[22]"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer."
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. expand/collapse author list , Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.
Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15 AND TYR-19, MASS SPECTROMETRY.
Tissue: Lung carcinoma.
[23]"TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells."
Hu X., Cui D., Moscinski L.C., Zhang X., Maccachero V., Zuckerman K.S.
Cytokine 37:155-162(2007) [PubMed: 17459720] [Abstract]
Cited for: FUNCTION AS RB1 KINASE, ENZYME REGULATION BY TGFB1, REPRESSION BY TGFB1.
[24]"Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line."
Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.
Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND TYR-15, MASS SPECTROMETRY.
Tissue: Prostate cancer.
[25]"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.
J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161, MASS SPECTROMETRY.
Tissue: Cervix carcinoma.
[26]"Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry."
Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R., Keri G., Wehland J., Daub H.
Mol. Cell. Proteomics 6:537-547(2007) [PubMed: 17192257] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15 AND TYR-19, MASS SPECTROMETRY.
Tissue: Leukemic T-cell.
[27]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-160 AND THR-161, MASS SPECTROMETRY.
Tissue: Cervix carcinoma.
[28]"Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF."
Pomerening J.R., Ubersax J.A., Ferrell J.E. Jr.
Mol. Biol. Cell 19:3426-3441(2008) [PubMed: 18480403] [Abstract]
Cited for: FUNCTION DURING THE M PHASE, MUTAGENESIS OF 14-THR-TYR-15.
[29]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-5; THR-14; TYR-15; TYR-19; SER-39; TYR-77; THR-161 AND THR-222, MASS SPECTROMETRY.
Tissue: Cervix carcinoma.
[30]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND TYR-15, MASS SPECTROMETRY.
Tissue: Cervix carcinoma.
[31]"Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells."
Tan F., Lu L., Cai Y., Wang J., Xie Y., Wang L., Gong Y., Xu B.-E., Wu J., Luo Y., Qiang B., Yuan J., Sun X., Peng X.
Proteomics 8:2885-2896(2008) [PubMed: 18655026] [Abstract]
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-89, MASS SPECTROMETRY.
Tissue: Cervix carcinoma.
[32]"Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons."
Yuan Z., Becker E.B.E., Merlo P., Yamada T., DiBacco S., Konishi Y., Schaefer E.M., Bonni A.
Science 319:1665-1668(2008) [PubMed: 18356527] [Abstract]
Cited for: FUNCTION AS FOXO1 KINASE, INTERACTION WITH FOXO1.
[33]"Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.
Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15 AND TYR-19, MASS SPECTROMETRY.
Tissue: Embryonic kidney.
[34]"Sequential phosphorylation of Nedd1 by Cdk1 and Plk1 is required for targeting of the gammaTuRC to the centrosome."
Zhang X., Chen Q., Feng J., Hou J., Yang F., Liu J., Jiang Q., Zhang C.
J. Cell Sci. 122:2240-2251(2009) [PubMed: 19509060] [Abstract]
Cited for: FUNCTION AS NEDD1 KINASE.
[35]"An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells."
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A., Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D., Wiley H.S., Qian W.-J.
J. Proteome Res. 8:3852-3861(2009) [PubMed: 19534553] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15 AND TYR-19, MASS SPECTROMETRY.
Tissue: Mammary epithelium.
[36]"Large-scale proteomics analysis of the human kinome."
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H.
Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-4; THR-5; THR-14; TYR-15; TYR-19; SER-39; SER-46; THR-141; TYR-160; THR-161; SER-178; TYR-181; THR-222; SER-233 AND SER-248, MASS SPECTROMETRY.
[37]"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15; TYR-19 AND THR-161, MASS SPECTROMETRY.
Tissue: Leukemic T-cell.
[38]"Lysine acetylation targets protein complexes and co-regulates major cellular functions."
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M.
Science 325:834-840(2009) [PubMed: 19608861] [Abstract]
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND LYS-6, MASS SPECTROMETRY.
[39]"Mitotic phosphorylation of Aki1 at Ser208 by cyclin B1-Cdk1 complex."
Nakamura A., Naito M., Arai H., Fujita N.
Biochem. Biophys. Res. Commun. 393:872-876(2010) [PubMed: 20171170] [Abstract]
Cited for: FUNCTION AS CC2D1A KINASE.
[40]"New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses."
Yoon C.-H., Miah M.A., Kim K.P., Bae Y.-S.
EMBO Rep. 11:393-399(2010) [PubMed: 20395957] [Abstract]
Cited for: FUNCTION IN G2 ARREST UPON DNA DAMAGE, PHOSPHORYLATION AT TYR-4 BY PKR/EIF2AK2, POLYUBIQUITINATION, MUTAGENESIS OF TYR-4.
[41]"The protein kinase Cdelta catalytic fragment is critical for maintenance of the G2/M DNA damage checkpoint."
LaGory E.L., Sitailo L.A., Denning M.F.
J. Biol. Chem. 285:1879-1887(2010) [PubMed: 19917613] [Abstract]
Cited for: PHOSPHORYLATION AT TYR-15.
[42]"Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition."
Timofeev O., Cizmecioglu O., Settele F., Kempf T., Hoffmann I.
J. Biol. Chem. 285:16978-16990(2010) [PubMed: 20360007] [Abstract]
Cited for: FUNCTION IN G2-M TRANSITION, DEPHOSPHORYLATION AT THR-14 AND TYR-15 BY CDC25, PHOSPHORYLATION AT THR-161 BY CDK7/CAK, INTERACTION WITH B-CYCLIN.
[43]"Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis."
Terrano D.T., Upreti M., Chambers T.C.
Mol. Cell. Biol. 30:640-656(2010) [PubMed: 19917720] [Abstract]
Cited for: FUNCTION AS BCL-XL/BCL2L1 KINASE, SUBCELLULAR LOCATION.
[44]"Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity."
Matthess Y., Raab M., Sanhaji M., Lavrik I.N., Strebhardt K.
Mol. Cell. Biol. 30:5726-5740(2010) [PubMed: 20937773] [Abstract]
Cited for: FUNCTION AS CASP8 KINASE.
[45]"Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2."
Chen S., Bohrer L.R., Rai A.N., Pan Y., Gan L., Zhou X., Bagchi A., Simon J.A., Huang H.
Nat. Cell Biol. 12:1108-1114(2010) [PubMed: 20935635] [Abstract]
Cited for: FUNCTION AS EZH2 KINASE.
[46]"Initial characterization of the human central proteome."
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.
BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract]
Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
[47]"CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore-microtubule attachment."
Itoh G., Kanno S., Uchida K.S., Chiba S., Sugino S., Watanabe K., Mizuno K., Yasui A., Hirota T., Tanaka K.
EMBO J. 30:130-144(2011) [PubMed: 21063390] [Abstract]
Cited for: FUNCTION AS CHAMP1 KINASE.
[48]"Mammalian cyclin-dependent kinases."
Malumbres M., Barbacid M.
Trends Biochem. Sci. 30:630-641(2005) [PubMed: 16236519] [Abstract]
Cited for: REVIEW ON SUBSTRATES, GENE FAMILY.
[49]"The decision to enter mitosis: feedback and redundancy in the mitotic entry network."
Lindqvist A., Rodriguez-Bravo V., Medema R.H.
J. Cell Biol. 185:193-202(2009) [PubMed: 19364923] [Abstract]
Cited for: REVIEW ON SUBCELLULAR TRANSLOCATION.
[50]"Cell cycle, CDKs and cancer: a changing paradigm."
Malumbres M., Barbacid M.
Nat. Rev. Cancer 9:153-166(2009) [PubMed: 19238148] [Abstract]
Cited for: REVIEW ON CELL CYCLE CONTROL AND INHIBITORS, GENE FAMILY.
[51]"Cdc2: a monopotent or pluripotent CDK?"
Hu X., Moscinski L.C.
Cell Prolif. 44:205-211(2011) [PubMed: 21535261] [Abstract]
Cited for: REVIEW ON CELL CYCLE CONTROL.
[52]"Cyclin dependent kinase 1 inhibitors: a review of recent progress."
Wang Q., Su L., Liu N., Zhang L., Xu W., Fang H.
Curr. Med. Chem. 18:2025-2043(2011) [PubMed: 21517772] [Abstract]
Cited for: REVIEW ON CELL CYCLE CONTROL AND INHIBITORS.
[53]"Checkpoint recovery in cells: how a molecular understanding can help in the fight against cancer."
Medema R.H., Macurek L.
F1000 Biol. Rep. 3:10-10(2011) [PubMed: 21655336] [Abstract]
Cited for: REVIEW ON CELL CYCLE CONTROL.
+Additional computationally mapped references.

Web resources

NIEHS-SNPs

Cross-references

Sequence databases

EMBL
GenBank
DDBJ		X05360 mRNA. Translation: CAA28963.1.
Y00272 mRNA. Translation: CAA68376.1.
D88357 mRNA. Translation: BAA26001.1.
AK291939 mRNA. Translation: BAF84628.1.
BT007004 mRNA. Translation: AAP35650.1.
AF512554 Genomic DNA. Translation: AAM34793.1.
AC022390 Genomic DNA. No translation available.
CH471083 Genomic DNA. Translation: EAW54204.1. Sequence problems.
BC014563 mRNA. Translation: AAH14563.1.
IPIIPI00026689.
IPI00073536.
PIRA29539.
RefSeqNP_001777.1. NM_001786.4.
NP_203698.1. NM_033379.4.
UniGeneHs.732435.

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1LC9model-A1-297[»]
ProteinModelPortalP06493.
SMRP06493. Positions 1-289.
ModBaseSearch...

Protein-protein interaction databases

DIPDIP-35N.
IntActP06493. 42 interactions.
MINTMINT-5000894.
STRINGP06493.

PTM databases

PhosphoSiteP06493.

Polymorphism databases

DMDM288558822.

2D gel databases

SWISS-2DPAGEP06493.

Proteomic databases

PRIDEP06493.

Protocols and materials databases

DNASU983.
StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000395284; ENSP00000378699; ENSG00000170312.
GeneID983.
KEGGhsa:983.
UCSCuc001jld.3. human.
uc001jlg.3. human.

Organism-specific databases

CTD983.
GeneCardsGC10P062539.
H-InvDBHIX0008851.
HGNCHGNC:1722. CDK1.
HPACAB003799.
HPA003387.
MIM116940. gene.
neXtProtNX_P06493.
PharmGKBPA165548298.
PA99.
GenAtlasSearch...

Phylogenomic databases

eggNOGCOG0515.
GeneTreeENSGT00630000089551.
HOVERGENHBG014652.
KOK02087.
OMAPNNDVWP.
OrthoDBEOG41NTMH.
PhylomeDBP06493.

Enzyme and pathway databases

BRENDA2.7.11.22. 2681.
Pathway_Interaction_DBfoxm1pathway. FOXM1 transcription factor network.
retinoic_acid_pathway. Retinoic acid receptors-mediated signaling.
ReactomeREACT_111045. Developmental Biology.
REACT_111102. Signal Transduction.
REACT_115566. Cell Cycle.
REACT_116125. Disease.
REACT_6850. Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
REACT_6900. Immune System.

Gene expression databases

ArrayExpressP06493.
BgeeP06493.
CleanExHS_CDC2.
GenevestigatorP06493.
GermOnlineENSG00000170312. Homo sapiens.

Family and domain databases

InterProIPR011009. Kinase-like_dom.
IPR000719. Prot_kinase_cat_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR002290. Ser/Thr_dual-sp_kinase_dom.
IPR008271. Ser/Thr_kinase_AS.
[Graphical view]
PfamPF00069. Pkinase. 1 hit.
[Graphical view]
SMARTSM00220. S_TKc. 1 hit.
[Graphical view]
SUPFAMSSF56112. Kinase_like. 1 hit.
PROSITEPS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00108. PROTEIN_KINASE_ST. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

BindingDBP06493.
NextBio4122.
SOURCESearch...

Entry information

Entry nameCDK1_HUMAN
AccessionPrimary (citable) accession number: P06493
Secondary accession number(s): A8K7C4, C9J497, O60764
Entry history
Integrated into UniProtKB/Swiss-Prot: January 1, 1988
Last sequence update: May 31, 2011
Last modified: May 16, 2012
This is version 166 of the entry and version 3 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human and mouse protein kinases

Human and mouse protein kinases: classification and index

Human chromosome 10

Human chromosome 10: entries, gene names and cross-references to MIM

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

to top of pageNames·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·Documents